Humoral #immunity after #LP81 monovalent #vaccines against a broad range of #SARS-CoV-2 #variants including #XEC, LP.8.1, NB.1.8.1, #XFG, and #BA32, https://etidiohnew.blogspot.com/2026/01/humoral-immunity-after-lp81-monovalent.html
Humoral #immunity after #LP81 monovalent #vaccines against a broad range of #SARS-CoV-2 #variants including #XEC, LP.8.1, NB.1.8.1, #XFG, and #BA32

Here's the latest SARS-CoV-2 variant picture for Japan to mid-May. Regrettably, the sample volumes shrank from April onwards, so the picture is uncertain.

The NB.1.8.1 "Nimbus" variant grew during May to 33%. It is probably dominant by now over XEC.*, which was declining.

#SARSCoV2 #COVID19 #Japan #NB_1_8_1 #Nimbus #XEC
🧵

Here's the latest variant picture for the United Kingdom, to late April.

The LP.8.1.* variant has taken over dominance, growing steadily to around 57% frequency.

The XEC.* variant has fallen to around 25%.

#COVID19 #UK #XEC #LP_8_1
🧵

Here's the latest variant picture for Australia, to early May.

XEC.* has been dominant, but declined to around 32%.

LP.8.1.* has grown to 23%, and XDV.* (driven by NB.1.8.1) grew to 18%.

#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV @auscovid19
🧵

Here's the latest variant picture for the United Kingdom, to late April.

The LP.8.1.* variant has taken over dominance, growing steadily to around 50% frequency.

The XEC.* variant has fallen to around 25%.

#COVID19 #UK #XEC #LP_8_1

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20UK.pdf

Here's the latest variant picture for Canada to late April.

The LP.8.1.* variant is now dominant, growing strongly to 56%.

The XEC.* variant has declined to around 18%.

#COVID19 #Canada #XEC #LP_8_1

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20Canada.pdf

Here's the latest variant picture for New Zealand, to early May.

DeFLuQE variants continue to dominate at around 40-80%

The XDV.* variant - driven by it’s latest sub-lineage NB.1.8.1 – is present, but only up to 11% so far.

#COVID19 #NZ #DeFLuQE #XEC #NB_1_8_1

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20NZ.pdf

Here's the latest variant picture for Australia, to mid-April.

XEC.* continues to dominate, but declined further to around 30%.

The next challenger now looks like LP.8.1.*, growing a bit faster to around 27%

XDV.*, driven by it’s latest sub-lineage NB.1.8.1, grew to around 19%, and it’s growth rate still looks the fastest.

#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV @auscovid19
🧵

Here's the latest variant picture for Europe (excluding the UK), to mid-April.

The LP.8.1.* variant took over dominance, growing steadily to around 43% frequency.

The XEC.* variant fell to around 21%.

#COVID19 #EUR #XEC #LP_8_1
🧵

Here's the latest variant picture for the United Kingdom, to late April.

The LP.8.1.* variant has taken over dominance, growing steadily to around 50% frequency.

The XEC.* variant has fallen to around 25%.

#COVID19 #UK #XEC #LP_8_1
🧵
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20UK.pdf